A potent inhibitor of adenosine deaminase. The drug is effective in the treatment of many lymphoproliferative malignancies, particularly hairy-cell leukemia. It is also synergistic with some other antineoplastic agents and has immunosuppressive activity.
For the treatment of hairy cell leukaemia refractory to alpha interferon.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.